Osteopore Ltd. ( (AU:OSX) ) has issued an update.
Osteopore Limited has achieved a significant milestone by having its craniomaxillofacial and oculoplastic implants listed on Singapore’s Ministry of Health Implant Subsidy List, which will enhance accessibility for patients and potentially increase market penetration. Additionally, the company has initiated financial strategies by drawing down Tranche 1 of its Redeemable Convertible Note with the Advance Opportunities Fund, securing A$2 million, which may bolster its financial position and operational capabilities.
More about Osteopore Ltd.
Osteopore Limited is a company in the medical industry that manufactures regenerative implants designed to support natural tissue regeneration. Their primary products include craniomaxillofacial and oculoplastic implants, with a market focus on innovative healthcare solutions.
YTD Price Performance: -45.71%
Average Trading Volume: 2,229,172
Technical Sentiment Signal: Buy
Current Market Cap: A$2.77M
For detailed information about OSX stock, go to TipRanks’ Stock Analysis page.